Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $315.0 million.

  • Maravai Lifesciences Holdings' Other Operating Expenses fell 99.96% to $60,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $284.0 million, marking a year-over-year increase of 8.59%. This contributed to the annual value of $315.0 million for FY2024, which is 116.58% up from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Other Operating Expenses stood at $315.0 million, which was up 116.58% from $145.5 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Operating Expenses registered a high of $315.0 million during FY2024, and its lowest value of $11.2 million during FY2021.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Other Operating Expenses value was $161.2 million (recorded in 2022), while the average stood at $207.2 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Other Operating Expenses plummeted by 81.45% in 2021, and later surged by 1,332.63% in 2022.
  • Maravai Lifesciences Holdings' Other Operating Expenses (Yearly) stood at $60.6 million in 2020, then slumped by 81.45% to $11.2 million in 2021, then soared by 1,332.63% to $161.2 million in 2022, then fell by 9.74% to $145.5 million in 2023, then surged by 116.58% to $315.0 million in 2024.